Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC

Shruti U. Gandhy(Texas A&M Health Science Center), Stephen Safe(Texas A&M University), Eric Hedrick(Florida Hospital Cancer Institute), Kyounghyun Kim(University of Cincinnati), Parisa Imanirad(Texas A&M University), J. Christopher Corton(Environmental Protection Agency), Un-Ho Jin(Texas A&M University), Vijayalekshmi Nair(Texas A&M University), Yating Cheng(Institute of Intelligent Machines)
Oncotarget
July 6, 2015
10.18632/oncotarget.4560
Cited by 33

Related Papers

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
|Journal of Clinical Oncology|2012|1.1k
Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)
|Journal of Clinical Oncology|2008|695
Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study
|Journal of Clinical Oncology|2008|623